Inotilone derivatives as coherent biological response modifier (cBMR)
申请人:Majeed Muhammed
公开号:US20110054018A1
公开(公告)日:2011-03-03
Optimal compositions of derivatives of 5-methyl-3(2H)-furanone compounds and phenylpropanoid polyketides related to inotilone, that exert biological response modification in health and disease, and their method of preparation, are disclosed. Methods of treating degenerative conditions stemming from over-expression of inducible nitric oxide synthase (iNOS) using these compositions are also disclosed.